Vitamin D3 injection in warts.
- Conditions
- cutaneous warts
- Registration Number
- CTRI/2019/07/020453
- Lead Sponsor
- DrRajitha alluri
- Brief Summary
cutaneous warts are usually treated by destructive modalities but these are associated with scarring and frequent recurrences and are not useful for treatment of multiple warts.This is an non-randomized,open label, interventional study to evaluate the safety and efficacy of intralesional vitamin D3 in cutaneous warts.0.2 ml of vit D3 was injected into the base of each wart.The injections were repeated 2weekly for a Maximum of 4sessions or until complete clearance.
A Maximum of 2 warts were treated per session and the primary outcome was evaluated by the clearance of both local and distant warts.The secondary outcome was evaluated by the recurrence of warts after a follow-up period of 6months.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 75
1.Patients with cutaneous warts 2.patients aged 15-60 years 3.Patients with no other treatment modalities in the past 3 months.
- 1.Pregnant and lactating females 2.Immunosupression including HIV 3.Any local or systemic inflammation or infection 4.Past history of meningitis o convulsions 5.plane warts 6.Genital warts 7.Patients with keloidal tendency.
- 8.Prior history of hypersensitivity to Vitamin D3 9.Previously diagnosed renal disease.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clearance of cutaneous warts at both primary and distant sites. 2,4,8 weeks
- Secondary Outcome Measures
Name Time Method 1.Adverse effects of vitamin D3 injection.
Trial Locations
- Locations (1)
Government general hospital
🇮🇳Guntur, ANDHRA PRADESH, India
Government general hospital🇮🇳Guntur, ANDHRA PRADESH, IndiaDrRajitha alluriPrincipal investigator9490890950dr.rajithaalluri@gmail.com